Insulin Aspart API is a high-purity pharmaceutical-grade Active Pharmaceutical Ingredient supplied by Jefferson Pharma India for formulation development and commercial manufacturing. The material is produced in GMP and ISO certified facilities and complies with internationally recognized pharmacopeial standards.
Insulin Aspart is a rapid-acting recombinant insulin analog widely used in pharmaceutical formulation manufacturing for endocrine-related products.
Jefferson Pharma India provides:
| Parameter | Details |
|---|---|
| API Name | Insulin Aspart |
| CAS No. | 116094-23-6 |
| Molecular Formula | C₂₅₆H₃₈₁N₆₅O₇₉S₆ |
| Molecular Weight | ~5825 g/mol |
| Purity | ≥ 99.0% (HPLC) |
| Physical Form | White lyophilized powder |
| Grade | Pharmaceutical Grade |
| Intended Use | For pharmaceutical formulation manufacturing only |
Packaging: Export-grade sealed pharmaceutical packaging with moisture protection and temperature control.
Storage: Store under refrigerated conditions (2°C to 8°C). Protect from light and moisture. Maintain cold-chain during transportation.
Jefferson Pharma India supplies Insulin Aspart API to pharmaceutical manufacturers, contract manufacturers, traders, and distributors worldwide with reliable cold-chain logistics and professional documentation support.
Active Pharmaceutical Ingredient (API) – Not for Direct Human or Veterinary Use.
+91 9373283509 / 9270190596
kaifh@jeffersonpharmaindia.com
S-2, Shivanjali, Friends Colony, Nagpur, Maharashtra – 440013.